Hernández-Fernández A, Ortiz-Ruiz AJ, De Arriba-de la Fuente F, Vicente-García V, Iniesta-López-Matencio P, Oñate-Sánchez RE. Cambra system in patients awaiting hematopoietic progenitor cell transplant and high caries risk. J Clin Exp Dent. 2017;9(5):e654-60.

 

doi:10.4317/jced.53617

http://dx.doi.org/doi:10.4317/jced.53617

 

References

1. Stewart BW, Wild CP (eds).World Cancer Report. Lyon: IARC. 2014.

 

 

2. Alwan A, Amstrong T, Bettcher D, Branca F, Chisholm D, Ezzati M, et al. Global Status Report on Noncommunicable diseases 2010. Geneva: OMS, 2011.

 

 

 

3. GLOBOCAN 2012 .Estimated Cancer Incidence. Mortality and Prevalence Worldwide in 2012. WHO. International Agency of research of cancer. Avaiable at: http://globocan.iarc.fr/Pages/summary_table_site_sel.aspx (Accesed Enero 2016).

 

 

 

4. National Cancer Intitute. Types of Treatment. Avaiable at http://www.cancer.gov/about-cancer/treatment/types. Accesed: October 2016.

 

 

 

5. Ariza-Heredia EJ, Chemaly RE. Infection Control Practices in Patients with Hematological Malignancies and Multidrug-resistant Organims: Special Considerations and Challenges. Clin Lymphoma Myeloma Leuk. 2014; 14 suppl: S104-10.
https://doi.org/10.1016/j.clml.2014.06.021
PMid:25486947

 

 

 

6. Saillard C, Sannini A, Chow-Chine L, Blanche JL, Brun JP, Mokart D. Febrile Neutropenia in Onco-hematology Patients Hospitalized in Intensive Care Unit. Bull Cancer. 2015;102: 349-59.
https://doi.org/10.1016/j.bulcan.2014.11.003
PMid:25799163

 

 

 

7. Elad S, Raber-Durlacher JE, Brennan MT, Saunders DP, Mank AP, Zadik Y, et al. Basic oral care for hematology-oncology patients and hematopoietic stem cell transplantation recipients: a position paper from the joint task force of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO) and the European Society for Blood and Marrow Transplantation (EBMT). Support Care Cancer. 2015;23: 223-36.
https://doi.org/10.1007/s00520-014-2378-x
PMid:25189149 PMCid:PMC4328129

 

 

 

8. Haverman TM, Raber-Durlacher JE, Rademacher WMH, Vokurka S, Epstein JB, Huisman C, et al. Oral Complications in Hematopoietic Stem Cell Recipients: The Role of Inflammation. Mediators of Inflamm. 2014;2014: 378281.
https://doi.org/10.1155/2014/378281
PMid:24817792 PMCid:PMC4003795

 

 

 

9. Sonis ST, Fey EG. Oral complications of cancer therapy. Oncology (Williston Park). 2002;16:680-6.

PMid:12108892

 

 

 

10. Tinoco-Aranjo JE, Orti-Raduan ES, Santos D, Colturato VA, Souta MP, Mauad MA. Oral health-related quality of life before hematopoietic stem cell transplantation. Clin Oral Investig. 2015;19: 2345-9.
https://doi.org/10.1007/s00784-015-1464-x
PMid:25825124

 

 

 

11. Fernades LL, Torres SR, Garnica M, De Souza Gonçalves L, Junior AS, de Vasconcellos AC, et al. Oral status of patients submitted to autologous hematopoietic stem cell transplantation. Support Care Cancer. 2014;22:15-21.
https://doi.org/10.1007/s00520-013-1940-2
PMid:23975228

 

 

 

12. López-Galindo MP, Bagán JV, Jiménez-Soriano Y, Alpiste F, Camps C. Valoración del estado dental y periodontal en un grupo de pacientes oncológicos, previo inicio de la quimioterapia. Med Oral Patol Oral Cir Bucal. 2006;11:E17-21.
PMid:16388287

 

 

 

13. Pritchard JK, Sullivan R. Children with cancer: driving the global agenda. Lancet Oncol. 2013;14:189-91.
https://doi.org/10.1016/S1470-2045(13)70043-3

PMid:23434336

 

 

 

14. American Academy of Pediatric Dentistry. Guideline on Caries-risk Assessment and Management for Infants, Children and Adolescents. Clinical Guidelines. 2014;37:132-9.

 

 

 

15. Featherstone JD, Domejean-Orliaguet S, Jenson L, Wolff M, Young DA. Caries Risk Assessment in Practice for Age 6 through Adult. J Calif Dent Assoc. 2007;35:703-10.
PMid:18044378

 

 

 

16. OMS (Organización Mundial de la Salud). Encuestas de salud bucodental. Métodos básicos. 4ª ed. Ginebra: OMS; 1997.

 

 

 

17. Fundación Científica AECC. Informe Annual 2015. Available at: (https://www.aecc.es/Investigacion/Documents/MemoriaFC_2015.pdf). Accesed: October 2016.

 

 

 

18. Forman D, Bray F, Brewster DH, Gombe Mbalawa C, Kohler B, Piñeros M, et al. Cancer incidence in five continets. Vol X . Lyon: IARC Scientific Publications No. 164, 2014.

 

 

 

19. Roman E, Smith A, Appleton S, Crouch S, Kelly R, Kinsey R, et al. Myeloid malignancies in the real-wordl: Occurrence, progression and survival in the UK's population-based Haematological Malignancy Research Network 2004-15. Cancer Epidemiol. 2016;42:186-98.
https://doi.org/10.1016/j.canep.2016.03.011
PMid:27090942 PMCid:PMC4911595

 

 

 

20. Deschler B, Lubbert M. Acute myeloid leukemia: epidemiology and etiology. Cancer. 2006;107:2099-107.
https://doi.org/10.1002/cncr.22233
PMid:17019734

 

 

 

21. Aoki J, Kanamori H, Tanaka M, Yamasaki S, Ogawa H, Iwato K et al. Impact of age on outcomes of allogeneic hematopoietic stem cell transpalntation with reduced intensity conditioning in elderly patients with acute myeloid leukemia.Am J Hematol. 2016;91:302-7.
https://doi.org/10.1002/ajh.24270
PMid:26663096

 

 

 

22. Ljungman P, Urbano-Ispizua A, Cavazzana-Calvo M, Demirer T, Dini G, Einsele H, et al. European Group of Blood and Marrow Transplantation. Allogenic and autologous transplantation for haematological diseases, solid tumors and inmune disorders: definitions and current practice in Europe. Bone Marrow Transplant. 2006;37:439-49.
https://doi.org/10.1038/sj.bmt.1705265
PMid:16444286

 

 

 

23. Estey E, Döhner H. Acute myeloid leukemia. Lancet. 2006;368:1894-907.
https://doi.org/10.1016/S0140-6736(06)69780-8

PMid:17126723

 

 

 

24. Llodra Calvo JC. Encuesta de salud oral en España 2010. RCOE (Revista del Ilustre Consejo General de Colegios de Odontólogos y Estomatólogos de España). 2012;17:13-41.